MedPath

The Role of Methycobalamin in Early Dementia Patients With Vitamin B12 Deficiency and Hyperhomocysteinaemia.

Phase 4
Completed
Conditions
Dementia With Vitamin B12 Deficiency
Registration Number
NCT00165711
Lead Sponsor
Eisai Co., Ltd.
Brief Summary

Patients who fit the inclusion criteria are admitted into the study. They are given 3 IV injection of MBL in the first week and one tablet three times a day for 16 weeks.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
Mattis dementia rating scale
Secondary Outcome Measures
NameTimeMethod
Category fluency test
CNPI
MMSE
Plasma homocysteine
Delirium rating scale
Plasma isoprostane

Trial Locations

Locations (1)

Chinese University of Hong Kong

🇨🇳

Hong Kong, Hong Kong, China

© Copyright 2025. All Rights Reserved by MedPath